Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.61SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.74SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAZSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.6.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BM.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.5.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.458SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
AG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
W.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.264.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.190SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.552SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.510SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.91SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.227SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.555SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.513SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HN.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-18860.4Singapore
XACSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
XZSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.36.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.221.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.242SYoung-STATACATGTCTCTGGGACCA20452176321782F-15766.7Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used